you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Nov 26, 16:00
2016.35 -8.00 (-0.40%)
Volume
AVERAGE VOLUME
5-Day
16,975
10-Day
17,699
30-Day
13,831
19,569
  • Prev. Close

    2024.35

  • Open Price

    2030.00

  • Bid Price (Qty.)

    2011.70 (1)

  • Offer Price (Qty.)

    2016.35 (4)

NSE Live

Nov 26, 15:59
2016.15 -8.30 (-0.41%)
Volume
AVERAGE VOLUME
5-Day
819,799
10-Day
715,360
30-Day
396,885
1,147,932
  • Prev. Close

    2024.45

  • Open Price

    2024.45

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2016.15 (4)

Financials

2020 2019 2018 2017 2016
Yearly Results of Ipca Laboratories (in Rs. Cr.) Mar '21 Mar '20 Mar '19 Mar '18 Mar '17  
Net Sales/Income from operations 5,139.16 4,367.43 3,633.15 3,219.21 3,156.66  
Other Operating Income -- -- -- -- --  
Total Income From Operations 5,139.16 4,367.43 3,633.15 3,219.21 3,156.66  
EXPENDITURE  
Consumption of Raw Materials 1,555.53 1,431.10 1,098.02 923.20 947.31  
Purchase of Traded Goods 197.68 204.65 167.87 168.30 161.84  
Increase/Decrease in Stocks -170.73 -155.05 -106.14 20.98 -1.73  
Power & Fuel -- -- -- -- --  
Employees Cost 948.84 870.79 752.24 712.78 674.93  
Depreciation 187.72 178.69 171.88 174.36 171.00  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,094.26 1,101.18 1,027.99 952.31 943.98  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,325.86 736.07 521.29 267.28 259.33  
Other Income 62.24 64.69 54.59 39.54 22.21  
P/L Before Int., Excpt. Items & Tax 1,388.10 800.76 575.88 306.82 281.54  
Interest 8.14 15.79 18.49 24.02 23.34  
P/L Before Exceptional Items & Tax 1,379.96 784.97 557.39 282.80 258.20  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,379.96 784.97 557.39 282.80 258.20  
Tax 239.19 132.51 102.48 49.69 69.91  
P/L After Tax from Ordinary Activities 1,140.77 652.46 454.91 233.11 188.29  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,140.77 652.46 454.91 233.11 188.29  
Equity Share Capital 25.37 25.27 25.27 25.24 25.24  
Reserves Excluding Revaluation Reserves 4,727.35 3,640.33 3,111.39 2,669.71 2,449.88  
Equity Dividend Rate (%) 400.00 250.00 150.00 50.00 50.00  
EPS Before Extra Ordinary  
Basic EPS 90.08 51.64 36.01 18.47 14.92  
Diluted EPS 90.08 51.60 36.01 18.47 14.92  
EPS After Extra Ordinary  
Basic EPS. 90.08 51.64 36.01 18.47 14.92  
Diluted EPS. 90.08 51.60 36.01 18.47 14.92  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited